MedTrace Logo

Registry of Local Recurrences After Breast-conserving Surgery

NCT05406661 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2023-10-19

No results posted yet for this study

Summary

The ReLoCC project is a prospective, multicenter, clinical study to register cases of local recurrence after breast-conserving surgery, in centers dedicated to the treatment of breast cancer, in Portugal and Spain.

The comparison of the results obtained will allow the optimization of the treatment, making it increasingly personalized.

Conditions

  • Breast Cancer Recurrent

Sponsors & Collaborators

  • Centro Hospitalar Universitário São João, EPE

    collaborator UNKNOWN

  • Universidade do Porto

    lead OTHER

Principal Investigators

  • José Luis Fougo, MD, PhD · Centro de Mama - Centro Hospitalar Universitário de São João

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406661 on ClinicalTrials.gov